What Nobody Tells You About Methylation and Pregnancy: MTHFR, Folic Acid, and Fetal Development

You've been told to take folic acid. Your prenatal vitamin contains 400mcg of it. Your GP says you're doing everything right. But if you carry an MTHFR gene variant — as up to 40% of people do — there's something critically important that nobody has told you about folic acid and pregnancy.

Folic acid is not the same as the folate your body needs. And for women with MTHFR, this distinction may be one of the most important facts of their reproductive health.

Folate vs Folic Acid: The Critical Distinction

Folate is the naturally occurring form of vitamin B9 — found in leafy greens, legumes, and liver. It exists in multiple forms in food, with the most biologically active being methylfolate (5-MTHF). Folic acid is the synthetic, oxidised form of folate used in supplements and food fortification. It is stable, cheap, and well-absorbed — but it must be converted to methylfolate before it can be used by cells. This conversion depends on the MTHFR enzyme.

The MTHFR Pregnancy Risk

When MTHFR is impaired, folic acid conversion is reduced. Unmetabolised folic acid (UMFA) accumulates in the bloodstream. And the methylfolate required for the most critical aspects of fetal development — neural tube closure, brain formation, DNA synthesis in rapidly dividing fetal cells — may be insufficient despite apparently adequate folic acid intake.

The neural tube closes in the first 28 days of pregnancy — typically before many women know they are pregnant. This window is the most critical for folate-dependent fetal development. Any folate insufficiency during this window has consequences that cannot be reversed later.

MTHFR and Pregnancy Outcomes

Research has found associations between maternal MTHFR variants and neural tube defects including spina bifida and anencephaly, recurrent miscarriage through impaired homocysteine clearance and vascular dysfunction, pre-eclampsia, placental abruption, low birth weight, and in some research, increased risk of neurodevelopmental conditions in offspring including autism spectrum disorder and ADHD.

These associations do not mean that MTHFR variants inevitably cause these outcomes. They mean that the biological vulnerability created by MTHFR — inadequate active folate and elevated homocysteine — increases risk in ways that are modifiable with appropriate supplementation.

What MTHFR-Positive Women Should Do

Switch from folic acid to methylfolate before conception and throughout pregnancy. Ensure adequate methylcobalamin B12 — essential for homocysteine remethylation and fetal nervous system development. Have homocysteine tested — elevated levels in early pregnancy are associated with adverse outcomes and are modifiable. Work with a GP or midwife who understands MTHFR — specialist guidance is particularly valuable in the preconception and first trimester period.

NeuroThrive™ products are food supplements and are not intended to diagnose, treat, or cure any medical condition. NeuroThrive MTHFR Support is not a prenatal supplement. Supplementation during pregnancy must always be supervised by your GP or midwife. This article is for educational purposes only.